Literature DB >> 25307358

A rapid method for preparation of the cerebrospinal fluid proteome.

Eivind Larssen1, Cato Brede, Anne Bjørnstad Hjelle, Kjell Birger Øysaed, Anne Bolette Tjensvoll, Roald Omdal, Peter Ruoff.   

Abstract

The cerebrospinal fluid (CSF) proteome is of great interest for investigation of diseases and conditions involving the CNS. However, the presence of high-abundance proteins (HAPs) can interfere with the detection of low-abundance proteins, potentially hindering the discovery of new biomarkers. Therefore, an assessment of the CSF subproteome composition requires depletion strategies. Existing methods are time consuming, often involving multistep protocols. Here, we present a rapid, accurate, and reproducible method for preparing the CSF proteome, which allows the identification of a high number of proteins. This method involves acetonitrile (ACN) precipitation for depleting HAPs, followed by immediate trypsination. As an example, we demonstrate that this method allows discrimination between multiple sclerosis patients and healthy subjects.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ACN-precipitation; Cerebrospinal fluid; LC-MS/MS; Sample preparation; Technology; Trypsination

Mesh:

Substances:

Year:  2014        PMID: 25307358     DOI: 10.1002/pmic.201400096

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  2 in total

1.  Sample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Protein.

Authors:  Ingeborg Kvivik; Grete Jonsson; Roald Omdal; Cato Brede
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-03

2.  Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid.

Authors:  Pablo Juanes-Velasco; Norma Galicia; Elisa Pin; Ricardo Jara-Acevedo; Javier Carabias-Sánchez; Rodrigo García-Valiente; Quentin Lecrevisse; Carlos Eduardo Pedreira; Rafael Gongora; Jose Manuel Sanchez-Santos; Héctor Lorenzo-Gil; Alicia Landeira-Viñuela; Halin Bareke; Alberto Orfao; Peter Nilsson; Manuel Fuentes
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.